Results 221 to 230 of about 4,201,815 (397)

Drug Addiction: Failure, Feast and Phoenix. [PDF]

open access: yesInt J Environ Res Public Health
Ayres TC, Taylor S.
europepmc   +1 more source

Drug addiction unveils a repressive methylation ceiling in EZH2-mutant lymphoma. [PDF]

open access: yesNat Chem Biol, 2023
Kwok HS   +6 more
europepmc   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

open access: yesMolecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková   +14 more
wiley   +1 more source

Early life adversity: Epigenetic regulation underlying drug addiction susceptibility. [PDF]

open access: yesMol Cell Neurosci, 2023
Winter JJ   +3 more
europepmc   +1 more source

The thalamus in drug addiction: from rodents to humans

open access: yesPhilosophical Transactions of the Royal Society B: Biological Sciences, 2018
Anna S. Huang   +4 more
semanticscholar   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

open access: yesMolecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim   +11 more
wiley   +1 more source

Astrocytic G Protein-Coupled Receptors in Drug Addiction. [PDF]

open access: yesEngineering (Beijing)
Zinsmaier AK, Nestler EJ, Dong Y.
europepmc   +1 more source

Home - About - Disclaimer - Privacy